RESUMO
Although excessive daytime sleepiness (EDS) is a frequent non-motor dysfunction in Parkinson's disease (PD), the exact pathophysiology remains elusive. This study investigates the relationship between daytime sleepiness and presynaptic monoamine transporter densities of the basal ganglia in patients with early PD. Sixty-four patients with early PD who were evaluated with positron emission tomography (PET) using 18F-N-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane were enrolled. EDS was evaluated with the Epworth Sleepiness Scale (ESS); nocturnal disabilities and nighttime sleep problems were assessed with Parkinson's Disease Sleep Scale 2nd version. PET images were normalized, and the standardized uptake value ratios (SUVRs) for caudate, putamen, globus pallidus, thalamus, and ventral striatum were obtained. The associations between regional SUVRs and ESS scores were analyzed. Among the patients studied, 12 had EDS defined as ESS > 10. The SUVR of the thalamus demonstrated a significant inverse relationship with ESS score, and thalamic monoamine availability appeared to predict EDS when controlling for covariates. The findings suggest that disrupted dopaminergic and serotonergic modulation of the thalamus may be implicated in EDS in PD. This in vivo study might contribute to elucidation of the neurobiological mechanism of hypersomnolence in PD.
Assuntos
Distúrbios do Sono por Sonolência Excessiva/metabolismo , Doença de Parkinson/metabolismo , Tálamo/metabolismo , Proteínas Vesiculares de Transporte de Monoamina/metabolismo , Idoso , Gânglios da Base/diagnóstico por imagem , Gânglios da Base/metabolismo , Distúrbios do Sono por Sonolência Excessiva/complicações , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Dopamina/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/complicações , Doença de Parkinson/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Serotonina/metabolismo , Tálamo/diagnóstico por imagemRESUMO
For patients with Parkinson's disease (PD), excessive daytime sleepiness (PD-EDS) is a debilitating non-motor symptom and may be affected by mood symptoms, especially depression and anxiety. Few neuroimaging works have attempted to identify the neural features of PD-EDS, but various findings were reported. The purpose of this study was to systematically review the literature on mood and neuroimaging correlates of PD-EDS. A MEDLINE, PubMed, EMBASE, and PsycInfo search for peer-reviewed original research articles on depression, anxiety, and neuroimaging in PD-EDS identified 26 studies on depression, nine on anxiety, and eight on neuroimaging. Half of the studies reported greater depression in PD-EDS-positive patients compared with PD-EDS-negative patients. There was a significantly positive correlation between depression and PD-EDS. Limited studies on anxiety in PD-EDS suggested a weak correlation between anxiety and EDS. For depression and anxiety, the effect sizes were medium when EDS was subjectively measured, but became small when EDS was objective measured. Current neuroimaging studies generally suggested diminished neural structural and functional features (eg, brain volume, white matter integrity as indicated by fractional anisotropy, and cerebral metabolism) in patients with PD-EDS. Future studies should apply objective and subjective measures of mood symptoms and EDS and improve the neuroimaging methodology via using multimodal techniques and whole-brain analysis to provide new clues on the mood and neural correlates of PD-EDS.
Assuntos
Afeto , Encéfalo/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/psicologia , Doença de Parkinson/diagnóstico por imagem , Doença de Parkinson/psicologia , Idoso , Ansiedade/diagnóstico por imagem , Ansiedade/fisiopatologia , Ansiedade/psicologia , Encéfalo/fisiopatologia , Depressão/diagnóstico por imagem , Depressão/fisiopatologia , Depressão/psicologia , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neuroimagem/métodos , Doença de Parkinson/fisiopatologia , Substância Branca/diagnóstico por imagem , Substância Branca/fisiopatologiaRESUMO
Frontotemporal brain sagging syndrome is a dementia associated with hypersomnolence, personality changes, and features of intracranial hypotension on magnetic resonance imaging. The literature is sparse with respect to treatment options; many patients simply worsen. We present a case in which this syndrome responded to lumbar dural reduction surgery. Postoperative magnetic resonance imaging indicated normalization of brain sagging and lumbar intrathecal pressure. Although no evidence of cerebrospinal leak was found, extremely thin dura was noted intraoperatively, suggesting that a thin and incompetent dura could result in this low-pressure syndrome. Clinicians who encounter this syndrome should consider dural reduction surgery as a treatment strategy.
Assuntos
Distúrbios do Sono por Sonolência Excessiva/complicações , Demência Frontotemporal/complicações , Demência Frontotemporal/cirurgia , Hipotensão Intracraniana/complicações , Procedimentos Neurocirúrgicos/métodos , Transtornos da Personalidade/complicações , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Demência Frontotemporal/diagnóstico por imagem , Humanos , Hipotensão Intracraniana/diagnóstico por imagem , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Transtornos da Personalidade/diagnóstico por imagemRESUMO
STUDY OBJECTIVES: Daytime sleepiness is a manifestation of multiple sleep and neurologic disorders. Few studies have assessed patterns of regional brain metabolism across different disorders of excessive daytime sleepiness. One such disorder, idiopathic hypersomnia (IH), is particularly understudied. METHODS: People with IH, narcolepsy (NT1), and non-sleepy controls underwent [18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) with electroencephalography (EEG). Participants were instructed to resist sleep and were awoken if sleep occurred. Voxel-wise parametric analysis identified clusters that significantly differed between each pair of groups, with a minimum cluster size of 100 voxels at a cluster detection threshold of p < 0.005. Correlations between glucose metabolism and sleep characteristics were evaluated. RESULTS: Participants (77% women) had IH (n = 16), NT1 (n = 14), or were non-sleepy controls (n = 9), whose average age was 33.8 (±10.7) years. Compared to controls, NT1 participants demonstrated hypermetabolism in fusiform gyrus, middle occipital gyrus, superior and middle temporal gyri, insula, cuneus, precuneus, pre- and post-central gyri, and culmen. Compared to controls, IH participants also demonstrated hypermetabolism in precuneus, inferior parietal lobule, superior and middle temporal gyri, and culmen. Additionally, IH participants demonstrated altered metabolism of the posterior cingulate. Most participants fell asleep. Minutes of N1 during uptake was significantly negatively correlated with metabolism of the middle temporal gyrus. CONCLUSION: NT1 and IH demonstrate somewhat overlapping, but distinct, patterns of regional metabolism.
Assuntos
Distúrbios do Sono por Sonolência Excessiva , Hipersonia Idiopática , Narcolepsia , Adulto , Encéfalo/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Feminino , Humanos , Hipersonia Idiopática/diagnóstico por imagem , Masculino , Narcolepsia/diagnóstico por imagem , SonoRESUMO
OBJECTIVES/BACKGROUND: Excessive daytime sleepiness (EDS) is a common disorder, which can manifest in isolation or in combination with other neurological or psychiatric disorders. We know relatively little about the mechanisms underlying the development of EDS and the clinical management of patients with EDS remains an unmet need. In this study, we hypothesised that thalamic dopaminergic function would be altered in subjects with EDS and we sought to investigate this by assessing [123I]FP-CIT Single Photon Emission Computed Tomography (SPECT) data, which is a molecular imaging marker of dopamine transporter (DAT). PATIENTS/METHODS: We performed a case-control study using people registered as healthy subjects in the Parkinson's Progression Markers Initiative database. We assessed and compared semi-quantified [123I]FP-CIT-SPECT in two groups of 21 healthy subjects with and without EDS, who were matched for age, gender, years of education and Rapid eyemovement (REM) sleep behaviour disorder (RBD) Questionnaire scores. RESULTS: Our findings show increased thalamic DAT binding in people with EDS compared to matched healthy subjects without EDS. Higher thalamic DAT binding also correlated with worse EDS scores. CONCLUSION: Our findings provide evidence that increased dopaminergic function in the thalamus may mediate excessive daytime sleepiness in humans.
Assuntos
Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Dopamina/metabolismo , Tálamo/metabolismo , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtorno do Comportamento do Sono REM/metabolismo , Transtorno do Comportamento do Sono REM/fisiopatologia , Tomografia Computadorizada de Emissão de Fóton Único/métodosRESUMO
BACKGROUND: Excessive daytime sleepiness (EDS) is a common and significant problem encountered in affective illness, however, the biological underpinnings of EDS in persons with psychiatric disorders are not clear. This study evaluated the associations between thalamic connectivity with cortical and subcortical brain regions with EDS in persons with and without depressive disorders (DD). METHODS: Resting-state functional connectivity magnetic resonance imaging scans from 67 unmedicated young to middle-aged women with current DD (n = 30), remitted DD (n = 13), and healthy controls (n = 24) were utilized to examine the associations between thalamic connectivity with cortical/subcortical structures and EDS. RESULTS: After correction for multiple comparisons and adjustment for age, habitual sleep duration, and depressive symptomatology, reduced resting-state connectivity between the bilateral thalamus and left rostral striatum (caudate/putamen) was significantly associated with EDS. LIMITATIONS: Causal inferences between thalamostriatal connectivity and EDS could not be determined. CONCLUSIONS: These results further implicate the role of the striatum and thalamus as central components of the experience of EDS. Further research is indicated to clarify the specific role these structures play in EDS in psychiatric disorders.
Assuntos
Transtorno Depressivo/complicações , Transtorno Depressivo/patologia , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Tálamo/patologia , Adulto , Mapeamento Encefálico , Estudos de Casos e Controles , Corpo Estriado/patologia , Transtorno Depressivo/diagnóstico por imagem , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Pessoa de Meia-Idade , Descanso , Tálamo/diagnóstico por imagemRESUMO
Importance: Aging is associated with excessive daytime sleepiness (EDS), which has been linked to cognitive decline in the elderly. However, whether EDS is associated with the pathologic processes of Alzheimer disease remains unclear. Objective: To investigate whether EDS at baseline is associated with a longitudinal increase in regional ß-amyloid (Aß) accumulation in a cohort of elderly individuals without dementia. Design, Setting, and Participants: This prospective analysis included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olmsted County, Minnesota. Of 2900 participants, 2172 (74.9%) agreed to undergo carbon 11-labeled Pittsburgh compound B positron emission tomography (PiB-PET). We included 283 participants 70 years or older without dementia who completed surveys assessing sleepiness at baseline and had at least 2 consecutive PiB-PET scans from January 1, 2009, through July 31, 2016, after excluding 45 (13.7%) who had a comorbid neurologic disorder. Main Outcomes and Measures: Excessive daytime sleepiness was defined as an Epworth Sleepiness Scale score of at least 10. The difference in Aß levels between the 2 consecutive scans (ΔPiB) in Aß-susceptible regions (prefrontal, anterior cingulate, posterior cingulate-precuneus, and parietal) was determined. Multiple linear regression models were fit to explore associations between baseline EDS and ΔPiB while adjusting for baseline age, sex, presence of the apolipoprotein E ε4 allele, educational level, baseline PiB uptake, global PiB positivity (standardized uptake value ratio ≥1.4), physical activity, cardiovascular comorbidities (obesity, hypertension, hyperlipidemia, and diabetes), reduced sleep duration, respiratory symptoms during sleep, depression, and interval between scans. Results: Of the initial 283 participants, mean (SD) age was 77.1 (4.8) years; 204 (72.1%) were men and 79 (27.9%) were women. Sixty-three participants (22.3%) had EDS. Baseline EDS was significantly associated with increased regional Aß accumulation in the anterior cingulate (B coefficient = 0.031; 95% CI, 0.001-0.061; P = .04), posterior cingulate-precuneus (B coefficient = 0.038; 95% CI, 0.006-0.069; P = .02), and parietal (B coefficient = 0.033; 95% CI, 0.001-0.065; P = .04) regions. Association of EDS with longitudinal Aß accumulation was stronger in participants with baseline global PiB positivity in the anterior cingulate (B coefficient = 0.065; 95% CI, 0.010-0.118; P = .02) and cingulate-precuneus (B coefficient = 0.068; 95% CI, 0.009-0.126; P = .02) regions. Conclusions and Relevance: Baseline EDS was associated with increased longitudinal Aß accumulation in elderly persons without dementia, suggesting that those with EDS may be more vulnerable to pathologic changes associated with Alzheimer disease. Further work is needed to elucidate whether EDS is a clinical marker of greater sleep instability, synaptic or network overload, or neurodegeneration of wakefulness-promoting centers. Early identification of patients with EDS and treatment of underlying sleep disorders could reduce Aß accumulation in this vulnerable group.
Assuntos
Peptídeos beta-Amiloides/metabolismo , Demência/diagnóstico por imagem , Demência/metabolismo , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/metabolismo , Idoso , Idoso de 80 Anos ou mais , Demência/epidemiologia , Distúrbios do Sono por Sonolência Excessiva/epidemiologia , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Masculino , Tomografia por Emissão de Pósitrons/tendências , Estudos Prospectivos , SonolênciaRESUMO
Excessive daytime sleepiness (EDS) is one of the earliest and most common non-motor symptoms of PD, substantially impacting on patient's quality of life. Using the Parkinson's Progression Markers Initiative database, we performed a case-control study to investigate whether dopaminergic deficit is associated with the development of EDS using dopaminergic specific single photon emission computed tomography (SPECT) molecular imaging of dopamine transporters (DAT). We enrolled 84 early de novo PD patients with EDS and 84 without EDS, who were matched for age, gender, age of diagnosis, years of education and disease duration. We assessed and compared semi-quantified [123I]FP-CIT SPECT, and motor and non-motor features among these two groups, alongside exploring the clinical and imaging correlates of EDS and the predictive significance of these markers in the development of EDS. PD patients with EDS had worse non-motor (MDS-UPDRS Part-I, Pâ¯<â¯0.001) and motor (MDS-UPRDS Part-II, Pâ¯=â¯0.005) experiences of daily living, as well as worse autonomic (SCOPA-AUT, Pâ¯<â¯0.0001) and cognitive (MoCA Pâ¯=â¯0.05) function, depression (GDS, Pâ¯=â¯0.002), and reduced caudate DAT ([123I]FP-CIT, Pâ¯=â¯0.024) compared to PD patients without EDS. Lower caudate [123I]FP-CIT values correlated with higher EDS scores (râ¯=â¯-0.192, Pâ¯=â¯0.013). Among patients without EDS, 47 PD patients (56%) developed EDS over a median follow-up of 36â¯months. Cox multivariate analysis, including all clinical and imaging data available, revealed that abnormal caudate [123I]FP-CIT uptake (Pâ¯=â¯0.030) and disease duration (Pâ¯=â¯0.018) were predictors for the development of EDS. Although our findings indicate that dopaminergic deficits in the caudate may be associated to EDS in patients with PD, the pathophysiological causality is debateable, given that dopamine caudate denervation may covary with dopaminergic involvement at other targets and with non-dopaminergic involvement.
Assuntos
Núcleo Caudado/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Doença de Parkinson/complicações , Idoso , Núcleo Caudado/efeitos dos fármacos , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Agonistas de Dopamina/uso terapêutico , Proteínas da Membrana Plasmática de Transporte de Dopamina/efeitos dos fármacos , Proteínas da Membrana Plasmática de Transporte de Dopamina/metabolismo , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/diagnóstico por imagem , Doença de Parkinson/tratamento farmacológico , Ligação Proteica/efeitos dos fármacos , Índice de Gravidade de Doença , Estatísticas não Paramétricas , Tomografia Computadorizada de Emissão de Fóton Único , Tropanos/farmacocinéticaRESUMO
INTRODUCTION: Many patients with Parkinson's disease (PD) report daytime sleepiness. Its etiology, however, is still not fully understood. The aim of this study was to examine if the amount of nigrostriatal dopaminergic degeneration is associated with subjective daytime sleepiness in patients with PD. PATIENTS AND METHODS: We investigated 21 patients with PD clinically and by means of [(123)I] FP-CIT-SPECT (DaTSCAN(R)). Each patient filled in the Epworth sleepiness scale (ESS), the Parkinson's Disease Sleep Scale (PDSS), and the self-rating depression scale according to Zung (SDS) to assess sleepiness, sleep quality, and depressive symptoms. RESULTS: The mean specific dopamine transporter binding in the 21 PD patients (60.8 +/- 10.4 years, nine females, median Hoehn and Yahr stage 2.0) was decreased. Nine patients were in Hoehn and Yahr stage 1 (58.7 +/- 6.6 years, four females; ESS score 7.4 +/- 4.5; PDSS score 105.1 +/- 30.9), the other 12 patients were in Hoehn and Yahr stage 2 (62.4 +/- 12.6 years, five females; ESS score 6.7 +/- 4.7, PDSS score 97.1 +/- 25.6). Age, gender, ESS, and PDSS scores were not significantly different in both groups. However, ESS scores showed an inverse correlation with mean DAT binding in the striatum (r = -0.627, p = 0.03), the caudate nucleus (r = -0.708, p = 0.01), and the putamen (r = -0.599, p = 0.04) in patients with Hoehn and Yahr stage 2. There was no correlation of the ESS score with age, disease duration, UPDRS motor score, PDSS score, or depression score. CONCLUSION: Subjective daytime sleepiness seems to be associated with dopaminergic nigrostriatal degeneration in early PD.
Assuntos
Corpo Estriado/metabolismo , Distúrbios do Sono por Sonolência Excessiva/etiologia , Dopamina/metabolismo , Doença de Parkinson/complicações , Substância Negra/metabolismo , Idoso , Corpo Estriado/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/diagnóstico por imagem , Doença de Parkinson/metabolismo , Doença de Parkinson/patologia , Índice de Gravidade de Doença , Estatísticas não Paramétricas , Substância Negra/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único/métodos , TropanosRESUMO
Deficiency of gamma-amino-butyrate aminotransferase (ABAT) is a rare inherited disorder. A six-month-old girl presented with hyper-somnolence, hyperkinetic movements of distal extremities during wakefulness, hypotonia, bi-pyramidal signs, and impaired response to sound and visual stimuli. Brain MRI at five months showed restricted diffusion along the internal capsule and genu of corpus callosum. A follow up MRI at 18months, showed hyperintensities in brainstem, external and internal capsule, 'trilaminated' appearance of posterior limb of internal capsule and dysmyelination of sub-cortical white matter. MRS showed a peak between 2.2ppm and 2.4ppm, corresponding to glutamine, glutamate and GABA. EEG was normal at six months but showed multifocal epileptiform discharges at 18months. Targeted exome sequencing revealed compound heterozygous missense variations in ABAT resulting in its reduced function. We report the novel association of hypersomnolence and hyperkinetic movement disorder with ABAT variations thus expanding the clinical spectrum of this uncommon neuro-metabolic disorder and discuss the emerging role of GABA in pathways regulating sleep-wake cycle and movement disorders.
Assuntos
4-Aminobutirato Transaminase/genética , Distúrbios do Sono por Sonolência Excessiva/genética , Heterozigoto , Hipercinese/genética , Mutação de Sentido Incorreto , 4-Aminobutirato Transaminase/deficiência , Encéfalo/diagnóstico por imagem , Encéfalo/fisiopatologia , Deficiências do Desenvolvimento/diagnóstico por imagem , Deficiências do Desenvolvimento/genética , Deficiências do Desenvolvimento/fisiopatologia , Diagnóstico Diferencial , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Feminino , Seguimentos , Humanos , Hipercinese/diagnóstico por imagem , Hipercinese/fisiopatologia , Lactente , Homologia de Sequência de AminoácidosRESUMO
Holmes' tremor is a low-frequency hand tremor and has varying amplitude at different phases of motion. It is usually unilateral and does not respond satisfactorily to drugs and thus considered irreversible. Structural lesions in the thalamus and brainstem or cerebellum are usually responsible for Holmes' tremor. We present a 23-year-old woman who presented with unilateral Holmes' tremor. She also had hypersomnolence and headache in the sitting posture. Her brain imaging showed brain sagging and deep brain swelling due to spontaneous intracranial hypotension (SIH). She was managed conservatively and had a total clinical and radiological recovery. The brain sagging with the consequent distortion of the midbrain and diencephalon was responsible for this clinical presentation. SIH may be considered as one of the reversible causes of Holmes' tremor.
Assuntos
Diencéfalo/fisiopatologia , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Cefaleia/fisiopatologia , Hipotensão Intracraniana/fisiopatologia , Imageamento por Ressonância Magnética , Mesencéfalo/fisiopatologia , Tremor/fisiopatologia , Diencéfalo/anormalidades , Diencéfalo/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Feminino , Hidratação , Decúbito Inclinado com Rebaixamento da Cabeça/fisiologia , Cefaleia/diagnóstico por imagem , Cefaleia/etiologia , Humanos , Hipotensão Intracraniana/complicações , Hipotensão Intracraniana/terapia , Mesencéfalo/anormalidades , Mesencéfalo/diagnóstico por imagem , Postura , Resultado do Tratamento , Tremor/diagnóstico por imagem , Tremor/etiologia , Adulto JovemRESUMO
Hepatic encephalopathy (HE) remains a diagnosis of exclusion due to the lack of specific signs and symptoms. Refractory HE is an uncommon but serious condition that requires the search of hidden precipitating events (i.e., portosystemic shunt) and alternative diagnosis. Hypothyroidism shares clinical manifestations with HE and is usually considered within the differential diagnosis of HE. Here, we describe a patient with refractory HE who presented a large portosystemic shunt and post-ablative hypothyroidism. Her cognitive impairment, hyperammonaemia, electroencephalograph alterations, impaired neuropsychological performance, and magnetic resonance imaging and spectroscopy disturbances were highly suggestive of HE, paralleled the course of hypothyroidism and normalized after thyroid hormone replacement. There was no need for intervention over the portosystemic shunt. The case findings support that hypothyroidism may precipitate HE in cirrhotic patients by inducing hyperammonaemia and/or enhancing ammonia brain toxicity. This case led us to consider hypothyroidism not only in the differential diagnosis but also as a precipitating factor of HE.
Assuntos
Amônia/metabolismo , Resistência a Medicamentos , Encefalopatia Hepática/tratamento farmacológico , Hiperamonemia/sangue , Hipotireoidismo/metabolismo , Cirrose Hepática Alcoólica/complicações , Antagonistas Adrenérgicos beta/uso terapêutico , Alcoolismo/complicações , Amônia/sangue , Antitireóideos/uso terapêutico , Encéfalo/diagnóstico por imagem , Carbimazol/uso terapêutico , Diagnóstico Diferencial , Distúrbios do Sono por Sonolência Excessiva/sangue , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Disartria/sangue , Disartria/diagnóstico por imagem , Disartria/etiologia , Eletroencefalografia , Embolização Terapêutica , Feminino , Bócio Nodular/sangue , Bócio Nodular/complicações , Bócio Nodular/tratamento farmacológico , Bócio Nodular/metabolismo , Encefalopatia Hepática/sangue , Encefalopatia Hepática/diagnóstico , Encefalopatia Hepática/metabolismo , Humanos , Hiperamonemia/complicações , Hipotireoidismo/sangue , Hipotireoidismo/diagnóstico , Hipotireoidismo/tratamento farmacológico , Cirrose Hepática Alcoólica/sangue , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Veia Porta/anormalidades , Veia Porta/diagnóstico por imagem , Derivação Portossistêmica Transjugular Intra-Hepática , Propranolol/uso terapêutico , Veias Renais/anormalidades , Veias Renais/diagnóstico por imagem , Tireotropina/sangue , Tiroxina/uso terapêutico , Tomografia Computadorizada por Raios X , Malformações Vasculares/sangue , Malformações Vasculares/complicações , Malformações Vasculares/terapiaRESUMO
INTRODUCTION: Excessive daytime sleepiness (EDS) is a common non-motor symptom in Parkinson's disease (PD), but its neuropathology remains elusive due to the limited studies and the inclusion of medicated patients. This current study examined the neural substrates of EDS in drug naïve PD patients. METHODS: A total of 76 PD patients in the early disease stages were recruited; 16 of them had EDS, while the remaining 60 did not. Resting state functional magnetic resonance imaging (rs-fMRI) was used to determine group differences (patients with EDS vs. patients without EDS) in spontaneous neural activity indicated by regional homogeneity (ReHo). Additionally, functional connectivity (FC) of the regions showing group differences in ReHo with the entire brain was performed. RESULTS: ReHo analysis controlling for gray matter volume, age, gender, general cognition, depression, postural instability gait difficulty, and rapid eye movement sleep behavior disorder showed decreased ReHo in the left cerebellum and inferior frontal gyrus, but increased ReHo in the left paracentral lobule in PD-EDS patients, compared with patients without EDS. FC analysis controlling for the same variables as in the analysis of ReHo revealed that the three regions showing ReHo differences had decreased FC with regions in the frontal, temporal, insular and limbic lobes and cerebellum in PDs with EDS. CONCLUSION: While decreases in ReHo and FC were found, increases in ReHo were also noted, implying both neural downregulation and compensatory mechanisms in early PD patients with EDS. Longitudinal studies are warranted to clarify the long-term impact of EDS in PD.
Assuntos
Mapeamento Encefálico , Encéfalo/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Imageamento por Ressonância Magnética , Doença de Parkinson/complicações , Descanso , Idoso , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Pessoa de Meia-Idade , Oxigênio/sangue , Índice de Gravidade de DoençaRESUMO
Subjects with isolated complaints of chronic daytime sleepiness are usually classified as "idiopathic hypersomniacs" and treated symptomatically. A group of these subjects was investigated during nocturnal sleep and daytime naps. In a subgroup of them, sleep was fragmented by very short alpha EEG arousals throughout the sleeping period. These short arousals are usually ignored in sleep analyses, but their impact is significant (in the 15 subjects identified with the syndrome, the mean sleep latency in multiple sleep latency tests was 5.1 +/- 1 min). These arousals are directly related to an abnormal increase in respiratory efforts during sleep (the mean peak inspiratory esophageal pressure measured in our subjects in the respiratory cycle just preceding a transient arousal was -33 +/- 7 cm H2O). Typically, an arousal occurs within one to three breaths of flow limitation associated with abrupt but limited reduction in tidal volume (ie, abnormal increase in upper airway resistance during sleep). The arousal restores normal breathing. Snoring was noted in association with these transient arousals in 10 of the 15 subjects; however, snoring was neither sufficient nor necessary for the identification of the clinical syndrome. Both sexes were equally represented in the affected group. All studied subjects had upper airway anatomy that was mildly abnormal. Nasal continuous positive airway pressure, used as an experimental tool, eliminated the daytime sleepiness (multiple sleep latency mean score = 13.5 min), the transient arousals (mean alpha EEG arousal index decreased from 31.3 +/- 12.4 to 8 +/- 2 per hour of sleep), and the abnormal upper airway resistance. Chronic daytime sleepiness is a major cause of social, economic, and medical impairment. Recognition of this syndrome and its cause is important, as specific treatments can be developed to eliminate the problem.
Assuntos
Resistência das Vias Respiratórias , Distúrbios do Sono por Sonolência Excessiva/etiologia , Adulto , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Distúrbios do Sono por Sonolência Excessiva/terapia , Eletroencefalografia , Feminino , Humanos , Laringe/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Polissonografia , Respiração com Pressão Positiva , Radiografia , Mecânica Respiratória , Fases do Sono , Ronco , SíndromeRESUMO
The slit ventricle syndrome (SVS), defined as intermittent shunt malfunction without substantial ventricular enlargement, is usually observed in shunted children with small, slitlike ventricles. This syndrome has been attributed to recurrent obstruction of the ventricular catheter, which then causes an increase of intracranial pressure. Only rarely has the SVS been reported in adults. We describe a 29-year-old woman whose shunt malfunction presented with long-lasting paroxysmal hypersomnia and was diagnosed with computed tomographic evidence of small lateral ventricles. This episodic hypersomnia presented every 2 to 3 weeks and each episode lasted 1 to 2 weeks. After revision of the ventricular catheter, her symptoms stopped and she remained well.
Assuntos
Ventrículos Cerebrais , Derivações do Líquido Cefalorraquidiano/efeitos adversos , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Transtornos do Sono-Vigília/diagnóstico por imagem , Adulto , Encefalopatias/diagnóstico por imagem , Encefalopatias/etiologia , Ventriculografia Cerebral , Diagnóstico Diferencial , Falha de Equipamento , Feminino , Humanos , SíndromeRESUMO
Inadequate treatment response occurs in approximately 40% of major depressive episodes (MDEs), and one approach to solve this is careful matching of treatment to the specific pathologies of MDE. One such biological abnormality is elevated monoamine oxidase A (MAO-A) levels, which occurs in the prefrontal and anterior cingulate cortex (PFC and ACC) during MDE; however, the subtypes for which this abnormality is most prominent are unknown. We hypothesized that MAO-A levels in the PFC and ACC are most elevated in MDE with greater severity and reversed neurovegetative symptoms (hypersomnia and either hyperphagia or weight gain). MAO-A VT (an index of MAO-A density) was measured using [(11)C]harmine positron emission tomography (PET) in 42 subjects with MDEs secondary to major depressive disorder and 37 healthy controls. The effect of severity and reversed neurovegetative symptoms on MAO-A VT in the PFC and ACC was analyzed using a multivariate analysis of variance (MANOVA). Greater severity and reversed neurovegetative symptoms were associated with elevated MAO-A VT in the PFC and ACC (MANOVA, severity: F(2,38)=5.44, p=0.008; reversed neurovegetative symptoms: F(2,38)=5.13, p=0.01). Increased MAO-A level, when greater severity and reversed neurovegetative symptoms are present, may explain the association of these clinical features with a preferential response to MAO inhibitors, which is especially well-evidenced for reversed neurovegetative symptoms in MDE. As MAO-A creates oxidative stress, facilitates apoptosis, and metabolizes monoamines, therapeutics opposing these processes are predicted to best treat MDE with greater severity and reversed neurovegetative symptoms.
Assuntos
Transtorno Depressivo Maior/complicações , Distúrbios do Sono por Sonolência Excessiva/etiologia , Hiperfagia/etiologia , Monoaminoxidase/metabolismo , Adulto , Radioisótopos de Carbono/farmacocinética , Córtex Cerebral/diagnóstico por imagem , Córtex Cerebral/efeitos dos fármacos , Transtorno Depressivo Maior/classificação , Transtorno Depressivo Maior/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Feminino , Harmina/farmacocinética , Humanos , Hiperfagia/diagnóstico por imagem , Imageamento por Ressonância Magnética , Masculino , Inibidores da Monoaminoxidase/farmacocinética , Tomografia por Emissão de Pósitrons , Ligação Proteica/efeitos dos fármacos , Ligação Proteica/fisiologia , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença , Estatísticas não Paramétricas , Adulto JovemAssuntos
Traumatismos Craniocerebrais/complicações , Traumatismos Craniocerebrais/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/etiologia , Lobo Frontal/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada de Emissão de Fóton ÚnicoAssuntos
Encéfalo/fisiopatologia , Distúrbios do Sono por Sonolência Excessiva/diagnóstico por imagem , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Síndrome de Kleine-Levin/diagnóstico por imagem , Síndrome de Kleine-Levin/fisiopatologia , Tomografia por Emissão de Pósitrons/métodos , Adolescente , Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Distúrbios do Sono por Sonolência Excessiva/metabolismo , Feminino , Fluordesoxiglucose F18 , Humanos , Síndrome de Kleine-Levin/metabolismo , Masculino , Compostos RadiofarmacêuticosRESUMO
A 24-year-old male with recurrent hypersomnia associated with decreased blood flow in the thalamus on single photon emission computed tomography (SPECT) is reported. In the hypersomnolent period, the decrease of blood flow in the left thalamus was revealed in the SPECT and slow waves appeared sporadically or sometimes as a burst on the electroencephalogram (EEG). In a phase of insomnia in the convalescent period there were almost no slow waves in the resting EEG but many slow waves appeared on hyperventilation EEG and the power spectrum at this hyperventilation resembled the power spectrum at the resting EEG in the hypersomnolent period. In the remission period there was no abnormal data in these testings.